Adaptimmune Therapeutics plc

Historical 13F Holders

Symbol
ADAP
CUSIP
00653A107
All holders as of
Q1 2025
Type
Equity
Class
SPONDS ADR
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 72 116 M $22.9 M
2024 Q4 83 124 M $67.0 M
2024 Q3 85 153 M $145 M
2024 Q2 83 155 M $151 M
2024 Q1 87 164 M $259 M
2023 Q4 82 146 M $116 M
2023 Q3 80 148 M $116 M
2023 Q2 91 145 M $134 M
2023 Q1 68 116 M $126 M
2022 Q4 72 114 M $167 M
2022 Q3 71 114 M $122 M
2022 Q2 80 115 M $195 M
2022 Q1 84 110 M $229 M
2021 Q4 93 114 M $426 M
2021 Q3 101 112 M $577 M
2021 Q2 90 112 M $476 M
2021 Q1 91 117 M $624 M
2020 Q4 97 118 M $638 M
2020 Q3 87 130 M $1.04 B
2020 Q2 90 128 M $1.28 B
2020 Q1 52 93.8 M $255 M
2019 Q4 45 65.0 M $78.0 M
2019 Q3 51 68.1 M $103 M
2019 Q2 60 68.2 M $274 M
2019 Q1 69 69.4 M $299 M
2018 Q4 85 69.2 M $398 M
2018 Q3 102 65.5 M $888 M
2018 Q2 94 56.0 M $665 M
2018 Q1 82 56.5 M $634 M
2017 Q4 73 52.1 M $348 M
2017 Q3 70 50.8 M $416 M
2017 Q2 56 48.1 M $216 M
2017 Q1 51 39.8 M $219 M
2016 Q4 40 29.8 M $121 M
2016 Q3 47 31.1 M $219 M
2016 Q2 47 31.9 M $260 M
2016 Q1 49 32.0 M $260 M
2015 Q4 50 20.8 M $250 M
2015 Q3 41 15.2 M $181 M
2015 Q2 45 21.0 M $384 M